Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites

Clinica Chimica Acta

Volumn 418, Issue , 2013, Pages 50-58

  Peitzsch, Mirko ^a   Pelzel, Daniela ^a   Glöckner, Stephan ^a   Prejbisz, Aleksander ^b   Fassnacht, Martin ^c,d   Beuschlein, Felix ^d   Januszewicz, Andrzej ^b   Siegert, Gabriele ^a   Eisenhofer, Graeme ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Catecholamines; LC MS MS; Metanephrines; Paraganglioma; Pheochromocytoma; Urine

Indexed keywords

3 O METHYLDOPAMINE; ADRENALIN; DECONJUGATED METANEPHRINE; DOPAMINE; METADRENALIN; NORADRENALIN; NORMETADRENALIN; UNCLASSIFIED DRUG;

3 O METHYLDOPAMINE URINE LEVEL; ADRENALIN URINE LEVEL; ADULT; AGED; ARTICLE; CATECHOLAMINE URINE LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPAMINE URINE LEVEL; FALSE NEGATIVE RESULT; FEMALE; HUMAN; LINEAR SYSTEM; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLITE; METANEPHRINE URINE LEVEL; METHYLATION; NORADRENALIN URINE LEVEL; NORMETANEPHRINE URINE LEVEL; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY FREE METANEPHRINE; URINE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84872952067     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.031     Document Type: Article

References (38)

1. Lenders J.W.M., Eisenhofer G., Mannelli M., Pacak K. Phaeochromocytoma. Lancet 2005, 366:665-675.
2. Pacak K., Eisenhofer G., Ahlman H., et al. Pheochromocytoma: recommendations for clinical practice from the first international symposium. Nat Clin Pract Endocrinol Metab 2007, 3:92-102.
3. Raber W., Raffesberg W., Bischof M., et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med 2000, 160:2957-2963.
4. Lenders J.W.M., Pacak K., Walther M.M., et al. Biochemical diagnosis of pheochromocytoma - which test is best?. JAMA 2002, 287:1427-1434.
5. Sawka A.M., Jaeschke R., Singh R.J., Young W.F. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. JCEM 2003, 88:553-558.
6. Unger N., Pitt C., Schmidt I.L., et al. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 2006, 154:409-417.
7. Vaclavik J., Stejskal D., Lacnak B., et al. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens 2007, 25:1427-1431.
8. Hickman P.E., Leong M., Chang J., Wilson S.R., McWhinney B. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology 2009, 41:173-177.
9. Eisenhofer G., Keiser H., Friberg P., et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. JCEM 1998, 83:2175-2185.
10. Eisenhofer G., Aneman A., Hooper D., Rundqvist B., Friberg P. Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans. J Neurochem 1996, 66:1565-1573.
11. Eisenhofer G., Coughtrie M.W.H., Goldstein D.S. Dopamine sulphate: an enigma resolved. Clin Exp Pharmacol Physiol 1999, 26:S41-S53.
12. Davidson D.F. Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines. Ann Clin Biochem 2002, 39:557-566.
13. Boyle J.G., Davidson D.F., Perry C.G., Connell J.M.C. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. JCEM 2007, 92:4602-4608.
14. Davidson D.F., Bradshaw N., Perry C.G., Lindsay R., Freel E.M. Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma. Ann Clin Biochem 2012, 49:486-490.
15. Whiting M.J. Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection. Ann Clin Biochem 2009, 46:129-136.
16. de Jong W.H.A., de Vries E.G.E., Wolffenbuttel B.H.R., Kema I.P. Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:1506-1512.
17. Taylor R.L., Singh R.J. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem 2002, 48:533-539.
18. Clark Z.D., Frank E.L. Urinary metanephrines by liquid chromatography tandem mass spectrometry: using multiple quantification methods to minimize interferences in a high throughput method. J Chromatogr B Analyt Technol Biomed Life Sci 2011, 879:3673-3680.
19. Gabler J., Miller A., Wang S. A simple liquid chromatography-tandem mass spectrometry method for measuring metanephrine and normetanephrine in urine. Clin Chem Lab Med 2011, 49:1213-1216.
20. Marrington R., Johnston J., Knowles S., Webster C. Measurement of urinary metadrenaline and normetadrenaline by liquid chromatography tandem mass spectrometry for the diagnosis of phaeochromocytoma. Ann Clin Biochem 2010, 47:467-475.
21. Simonin J., Gerber-Lemaire S., Centeno C., et al. Synthetic calibrators for the analysis of total metanephrines in urine: revisiting the conditions of hydrolysis. Clin Chim Acta 2012, 413:998-1003.
22. Peitzsch M, Prejbisz A, Kroiss M et al. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultra performance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. Ann Clin Biochem in press. http://dx.doi.org/10.1258/acb.2012.012112.
23. Lagerstedt S.A., O'Kane D.J., Singh R.J. Measurement of plasma free metanephrine and normetanephrine by liquid chromatographym-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem 2004, 50:603-611.
24. Peaston R.T., Graham K.S., Chambers E., van der Molen J.C., Ball S. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin Chim Acta 2010, 411:546-552.
25. Petteys J.B., Graham K.S., Parnás M.L., Holt C., Frank E.L. Performance characteristics of an LC-MS/MS method for the determination of plasma metanephrines. Clin Chim Acta 2012, 413:1459-1465.
26. Peaston R.T., Weinkove C. Measurement of catecholamines and their metabolites. Ann Clin Biochem 2004, 41:17-38.
27. Roberts N.B., Higgins G., Sargazi M. A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage. Clin Chem Lab Med 2010, 48:81-87.
28. Boomsma F., Alberts G., Vaneijk L., Manintveld A.J., Schalekamp M.A.D.H. Optimal collection and storage-conditions for catecholamine measurements in human plasma and urine. Clin Chem 1993, 39:2503-2508.
29. Miki K., Sudo A. Effect of urine pH, storage time, and temperature on stability of catecholamines, cortisol, and creatinine. Clin Chem 1998, 44:1759-1762.
30. Willemsen J.J., Ross H.A., Lenders J.W.M., Sweep F.C.G.J. Stability of urinary fractionated metanephrines and catecholamines during collection, shipment, and storage of samples. Clin Chem 2007, 53:268-272.
31. Chan E.C.Y., Wee P.Y., Ho P.C. Evaluation of degradation of urinary catecholamines and metanephrines and deconjugation of their sulfoconjugates using stability-indicating reversed-phase ion-pair HPLC with electrochemical detection. J Pharm Biomed Anal 2000, 22:515-526.
32. Lam R.W., Artal R., Fisher D.A. Radioimmunoassay for free and conjugated urinary metanephrine. Clin Chem 1977, 23:1264-1267.
33. Goldstein D.S., Swoboda K.J., Miles J.M., et al. Sources and physiological significance of plasma dopamine sulfate. JCEM 1999, 84:2523-2531.
34. de Jong W.H.A., Eisenhofer G., Post W.J., Muskiet F.A.J., de Vries E.G.E., Kema I.P. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. JCEM 2009, 94:2841-2849.
35. Eisenhofer G., Aneman A., Friberg P., et al. Substantial production of dopamine in the human gastrointestinal tract. JCEM 1997, 82:3864-3871.
36. Brown M.J., Allison D.J. Renal conversion of plasma dopa to urine dopamine. Br J Clin Pharmacol 1981, 12:251-253.
37. Kairisto V., Koskinen P., Mattila K., et al. Reference intervals for 24-H urinary normetanephrine, metanephrine, and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. Clin Chem 1992, 38:416-420.
38. Skitek M. Upper reference limits for urinary catecholamines, metanephrines and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. Clin Chem Lab Med 2002, 40:1061-1062.